Skip to content

Study · Animal study (in vivo) · calf and rabbit · 1995

3 results

Effect of administration of serum thymic factor (FTS) in calves and rabbits infected with bovine immunodeficiency-like virus.

Hirai N, Furuyama H, Awaya A, Onuma M

The Journal of veterinary medical science1 Apr 1995Cited by 7 (Europe PMC)

PMID7492651 (opens in a new tab)DOI10.1292/jvms.57.307 (opens in a new tab)PepBankPUB-07492651
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In BIV-infected calves, no delay in antibody responses against foreign proteins was observed after FTS administration.

    In plain wordsIn BIV-infected calves, antibody responses against foreign proteins showed no delay after FTS treatment.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    DecreaseAntibody response delay
    Study

    calfn: not reported in source

    BIV-infected calves
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    After FTS administration, however, no delay of antibody responses against foreign proteins was observed in BIV-infected calves.
    1 context sentence
    Summary · context
    The effect of serum thymic factor (FTS) administration in bovine immunodeficiency-like virus (BIV)-infected calves and rabbits was examined.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In BIV-infected calves, FTS restored depressed macrophage chemiluminescence responses to levels comparable with control calves.

    In plain wordsIn BIV-infected calves, FTS restored macrophage activity to levels similar to control calves.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    IncreaseMacrophage chemiluminescence
    Study

    calfn: not reported in source

    BIV-infected calves
    Comparator
    control calves
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Though the chemiluminescence (CL) responses of macrophages in BIV-infected calves were significantly depressed (p < 0.05), FTS administration resulted in the recovery of the CL responses in the BIV-infected calves comparable to those in the control calves.
    1 context sentence
    Summary · context
    The effect of serum thymic factor (FTS) administration in bovine immunodeficiency-like virus (BIV)-infected calves and rabbits was examined.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In BIV-infected rabbits, depression of antibody responses versus uninfected rabbits was no longer significant after FTS administration.

    In plain wordsIn BIV-infected rabbits, antibody responses were no longer significantly lower than in uninfected rabbits after FTS treatment.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    No significant changeAntibody responses
    Study

    rabbitn: not reported in source

    BIV-infected rabbits
    Comparator
    uninfected rabbits
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Antibody responses against foreign proteins in BIV-infected rabbits were significantly depressed (p < 0.025) as compared with those in uninfected rabbits, though the depression became no significant after FTS administration.
    1 context sentence
    Summary · context
    The effect of serum thymic factor (FTS) administration in bovine immunodeficiency-like virus (BIV)-infected calves and rabbits was examined.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.